Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of a Doppler-Guided Uterine Artery Occlusion Device as Treatment for the Reduction of Fibroid-Associated Bleeding

NCT00496067 is registered in ClinicalTrials.gov with Ethicon, Inc. as lead sponsor.

NCT NCT00496067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00496067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of a Doppler-Guided Uterine Artery Occlusion Device as Treatment for the Reduction of Fibroid-Associated Bleeding
Lead sponsor
Ethicon, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2007
Completion date
December 31, 2009
Enrollment
91 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

menorrhagia, uterine fibroids